Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06429241

Evaluate the Distribution and Dynamic Behavior of TH-SC01 Cells in Vivo in Patients With Perianal Fistula

A Phase I Clinical Study Evaluating the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Perianal Fistula

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
8 (estimated)
Sponsor
Jiangsu Topcel-KH Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the distribution and dynamic behavior of Nuclide labeled TH-SC01 cells in vivo in patients with perianal fistula

Detailed description

A Phase I clinical study evaluating the distribution and dynamic behavior of Nuclide labeled TH-SC01 cells in vivo in patients with perianal fistula

Conditions

Interventions

TypeNameDescription
BIOLOGICALMesenchymal Stem Cells (MSCs)single dose injection (120 million cells)

Timeline

Start date
2024-04-08
Primary completion
2024-11-01
Completion
2025-12-01
First posted
2024-05-24
Last updated
2024-06-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06429241. Inclusion in this directory is not an endorsement.